Vitamin D receptor gene polymorphism influences lipid profile in patients with juvenile idiopathic arthritis
- 20 August 2018
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 38 (1) , 117-124
Abstract
Vitamin D receptor (VDR) gene FokI (rs2228570) polymorphism was postulated to influence outcome of several inflammatory diseases. The aim of this study was to evaluate the influence of rs2228570 polymorphism on lipid profile and on outcome in patients with juvenile idiopathic arthritis (JIA) treated with etanercept. A total of 153 subjects (62 JIA patients and 91 controls) were screened for the rs2228570 using the PCR-RFLP method. Lipid profile (cholesterol, triacylglycerol, HDL-C, and LDL-C) was determined using standard biochemical analysis in controls, while in JIA patients, it was determined prior to and 12 months after anti-TNF (etanercept) therapy. Clinical outcome was assessed using the JIA—American College of Rheumatology (ACR) response criteria. There were significant differences in the distribution of genotypes (p = 0.024) and alleles (p = 0.006; OR = 2.222, 95% CI 1.136–4.348) of the rs2228570 between patients and controls. Etanercept treatment significantly increased HDL-C levels (p = 0.006) in JIA patients with FF genotype in comparison to baseline values. No significant differences were seen in JIA—ACR 30/50/70 responses at month 12 between FF and Ff/ff genotype carriers. This is the first study to demonstrate the protective effect of the VDR FokI FF genotype on lipid profile in JIA patients treated with etanercept. However, this has to be confirmed in a larger cohort of patients.Keywords
Funding Information
- Ministry of Education, Science, and Technological Development of the Republic of Serbia (III41018)
This publication has 35 references indexed in Scilit:
- Vitamin D receptor agonists’ anti‐inflammatory propertiesAnnals of the New York Academy of Sciences, 2014
- Lipid Profiles Alter from Pro-Atherogenic into Less Atherogenic and Proinflammatory in Juvenile Idiopathic Arthritis Patients Responding to Anti TNF-α TreatmentPLOS ONE, 2014
- Association of disease activity and anti-rheumatic treatment in juvenile idiopathic arthritis with serum lipid profiles: A prospective studySeminars in Arthritis and Rheumatism, 2013
- Relationship between inflammatory markers, oxidant–antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritisClinical Research in Cardiology, 2012
- Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent PopulationPediatrics, 2009
- Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosusAnnals of the Rheumatic Diseases, 2009
- Vitamin D in systemic lupus erythematosusCurrent Opinion in Rheumatology, 2008
- Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyArthritis Research & Therapy, 2008
- Cytokine Pathways and Joint Inflammation in Rheumatoid ArthritisNew England Journal of Medicine, 2001
- The Polymorphic N Terminus in Human Vitamin D Receptor Isoforms Influences Transcriptional Activity by Modulating Interaction with Transcription Factor IIBMolecular Endocrinology, 2000